Search companies or stocks...
FULCFulcrum Therapeutics, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases…
Current stock price of Fulcrum Therapeutics, Inc. (FULC) stock is $3.850. The stock price is -0.52% lower in the session. The intraday range can be seen from this page. Volume of Fulcrum Therapeutics, Inc. (FULC) stock is 1.63M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Fulcrum Therapeutics, Inc. (FULC) can change with earnings, company news, and overall market sentiment. Fulcrum Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Fulcrum Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for FULC on this page is -3.56. EPS on this page is -1.08. Compare those figures with peers and growth expectations before deciding if the current Fulcrum Therapeutics, Inc. price is justified.
Historical performance for Fulcrum Therapeutics, Inc. (FULC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how FULC reacted to past earnings and market events.
Buying Fulcrum Therapeutics, Inc. (FULC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
